- Patient participation in early phase clinical trials in diabetes can reduce risks and accelerate “go, no-go” decisions
- Early phase clinical trials that recruit patients with diabetes require appropriate inclusion/exclusion criteria that consider comorbidities and concomitant medications thereby protecting the safety of participants while providing useful information
- Older patients, those in the pediatric and adolescent age groups, and women of childbearing potential require specific risk management strategies